| Melbana Energy Limited (MAY) ORDINARY FULLY PAID |
Energy |
$86 |
Block 9 Amistad Field Development Approved
|
11 Sep 2024 9:21AM |
$0.019 |
$0.026 |
risen by
34.21%
|
|
MAY - Price-sensitive ASX Announcement
Full Release
Key Points
- Initial development of Unit 1B formally approved and on track for Q1 2025.
- Construction approval received for the next Unit 1B well pad. Additional pads progressing through permitting.
- Oil truck/tankers have arrived in country. All export approvals received.
- Oil offtake contract terms being finalized with an international oil trader.
- Remediation of existing Unit 1B production well planned for November.
- Export of initial oil cargo on track for end of 2024.
- Andrew Purcell commented on transitioning from exploration to production.
- Focus remains on increasing production from the 46 million barrels of Contingent Resource.
- Study of Alameda-3 appraisal well results continuing.
- Formalizing a joint marketing and sales agreement with all Block 9 stakeholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$13,925 |
Appendix 3X - David Clarke
|
11 Sep 2024 9:21AM |
$64.550 |
$71.670 |
risen by
11.03%
|
|
| Brightstar Resources Limited (BTR) ORDINARY FULLY PAID |
Materials |
$321 |
High-grade gold returned at Menzies Link Zone Deposit
|
11 Sep 2024 9:20AM |
$0.017 |
$0.680 |
risen by
3,900%
|
|
BTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Assays received for five diamond drill holes at Link Zone deposit.
- Drilling part of a larger +30,000m program targeting Merriyulah and Golden Dicks deposits.
- High-grade intercepts include 12.0m at 11.90 g/t Au with a peak of 55.8 g/t Au.
- Geotechnical and metallurgical assessments are ongoing.
- Potential small-scale mining ahead of larger operations being studied in a Definitive Feasibility Study.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cavalier Resources Limited (CVR) ORDINARY FULLY PAID |
Materials |
$12 |
Discovery - 4.37% Titanium Intercept at Ella's Rock
|
11 Sep 2024 9:19AM |
$0.135 |
$0.210 |
risen by
55.56%
|
|
CVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of initial XRF assaying on 2,398m of aircore drilling at Ella’s Rock.
- High titanium values identified, including a peak of 4.37% Ti over 1m from 24m.
- Confirmatory laboratory assays validated XRF findings in drill hole ERAC035.
- Four new anomalous LCT/titanium targets identified north of Ella’s Rock.
- Further geochemical and lithogeochemical analyses are underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
11 Sep 2024 9:18AM |
$3.060 |
$2.590 |
fallen by
15.36%
|
|
| WAM Active Limited (WAA) ORDINARY FULLY PAID |
Financials |
$61 |
August 2024 Investment Update
|
11 Sep 2024 9:18AM |
$0.880 |
$0.805 |
fallen by
8.52%
|
|
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$13,925 |
ASX Announces New Chair as Damian Roche Retires
|
11 Sep 2024 9:18AM |
$64.550 |
$71.670 |
risen by
11.03%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$735 |
Update - Notification of buy-back - PPM
|
11 Sep 2024 9:16AM |
$1.350 |
$1.655 |
risen by
22.59%
|
|
| Kalamazoo Resources Limited (KZR) ORDINARY FULLY PAID |
Materials |
$20 |
Update - Proposed issue of securities - KZR
|
11 Sep 2024 9:16AM |
$0.084 |
$0.090 |
risen by
7.14%
|
|
| Kalamazoo Resources Limited (KZR) ORDINARY FULLY PAID |
Materials |
$20 |
Kalamazoo Receives Additional Placement Commitment
|
11 Sep 2024 9:15AM |
$0.084 |
$0.090 |
risen by
7.14%
|
|
KZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Kalamazoo Resources Limited received an additional $100,000 placement commitment.
- Total placement commitment now stands at $0.375 million.
- Approximately 4,687,500 shares to be issued at $0.08 per share.
- Shares to be issued under ASX Listing Rule 7.1.
- Placement is at a 16.7% discount to the last closing price of $0.096.
- Major shareholders show increased support by participating in the placement.
- Kalamazoo Resources has a portfolio of gold and base metals projects in various regions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$612 |
Update - Notification of buy-back - RF1
|
11 Sep 2024 9:15AM |
$3.130 |
$2.850 |
fallen by
8.95%
|
|
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$32,844 |
Update regarding Rightmove plc
|
11 Sep 2024 9:15AM |
$202.480 |
$248.600 |
risen by
22.78%
|
|
REA - Price-sensitive ASX Announcement
Full Release
Key Points
- REA Group made a non-binding proposal for Rightmove plc.
- Proposal includes 305 pence in cash and 0.0381 REA shares for each Rightmove share.
- Total offer value implies 705 pence per Rightmove share.
- Proposal was rejected by the Rightmove Board on 10 September 2024.
- The offer represents a 27% premium to Rightmove's share price as of 30 August 2024.
- Rightmove shareholders would hold approximately 18.6% of the combined group post-transaction.
- REA expects rapid deleveraging post-acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Visionflex Group Limited (VFX) ORDINARY FULLY PAID |
Health Care |
$8 |
Trading Update
|
11 Sep 2024 9:13AM |
$0.004 |
$0.003 |
fallen by
37.50%
|
|
VFX - Price-sensitive ASX Announcement
Full Release
Key Points
- Visionflex signed a 12-month agreement with Kha Loc Medical in Vietnam for a virtual health trial.
- First shipment of Visionflex's virtual health hardware and software solution to Vietnam.
- Potential for further shipments and increased volumes based on trial results.
- Visionflex signed a 12-month agreement with Anglicare to trial its virtual health solution at three aged care sites.
- Anglicare may expand the deployment of Visionflex’s solution if the trial is successful.
- Visionflex is a global virtual healthcare platform improving patient care across various sectors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$133 |
Boutique Fitness Studios Presentation
|
11 Sep 2024 9:13AM |
$1.420 |
$1.305 |
fallen by
8.10%
|
|
VVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Viva Leisure (Viva) has entered a binding agreement for a strategic investment of 34% in Boutique Fitness Studios (BFS).
- The investment of ~$2 million will be funded from existing cash reserves and bank facilities.
- BFS is the Australian and New Zealand Master Franchisee of four brands from Xponential Fitness (NYSE:XPOF): Rumble Boxing, Club Pilates, StretchLab, and CycleBar.
- Viva has an option to acquire the entire BFS business within 24 months at a pre-determined value.
- The BFS founders will stay on with an earn-out opportunity to drive the business and launch in New Zealand.
- The investment includes provisions for implementing Viva technology such as Viva Pay and The Hub across the BFS network.
- BFS currently operates 48 studios with 106 licenses sold across all four brands, expecting to open an additional 25 studios in the next 12 months.
- Viva will secure a position on the BFS Board and aims to integrate BFS brands into its Viva Pass product by H2-FY2025.
- The investment is fully funded with existing cash and banking facilities, and completion is expected before the end of September 2024.
- BFS network is projected to generate system-wide sales of approximately $25 million per annum once fully integrated.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Viva Leisure Limited (VVA) ORDINARY FULLY PAID |
Consumer Discretionary |
$133 |
Viva acquires strategic interest in Boutique Fitness Studios
|
11 Sep 2024 9:12AM |
$1.420 |
$1.305 |
fallen by
8.10%
|
|
VVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Viva Leisure Limited acquired a 34% strategic interest in Boutique Fitness Studios (BFS) for $2.0 million.
- BFS is the Australian and New Zealand Master Franchisee of four Xponential Fitness brands: Rumble Boxing, Club Pilates, StretchLab, and CycleBar.
- Viva Leisure has an option to acquire up to 100% of BFS.
- Investment is aimed at diversifying Viva's business and integrating Viva's technology, including Viva Pay and The Hub, into BFS.
- BFS operates 48 studios with 106 licenses sold and plans to open an additional 25 studios in the next 12 months.
- BFS network is expected to generate approximately $25.0 million in sales annually.
- Viva aims to incorporate BFS brands into its Viva Pass product, to be launched in H2-FY2025.
- Investment is fully funded with existing cash and banking facilities.
- Viva Leisure secures a position on the BFS Board as part of the investment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Quality Global Growth Fund (Managed Fund) (WCMQ) |
Financials |
$405 |
Investment Update 31 August 2024
|
11 Sep 2024 9:12AM |
$8.690 |
$11.190 |
risen by
28.77%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$45 |
Successful Completion of $5M On-Market Share Buyback
|
11 Sep 2024 9:11AM |
$0.140 |
$0.150 |
risen by
7.14%
|
|
| Patagonia Lithium Ltd (PL3) ORDINARY FULLY PAID |
Materials |
$6 |
Strong Results Achieved from Well Three at Formentera
|
11 Sep 2024 9:11AM |
$0.072 |
$0.048 |
fallen by
33.33%
|
|
PL3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Patagonia Lithium Ltd (ASX:PL3) announces strong assay results from the third well (JAM24-03) at Formentera.
- Lithium assay values range from 336 to 470ppm.
- High porosity noted, with lithium values concentrating at depth.
- Well lined with PVC tubing; a 48-hour pump test is planned.
- Ongoing drilling with well 4 (JAM24-10) underway.
- Positive trends in lithium concentration over a deep aquifer interval.
- 19,400L of water pumped during tests, with successful 200L pump tests at various depths.
- The company is also exploring other projects in the lithium triangle of Argentina.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$394 |
Investment Update and NTA Statement 31 August 2024
|
11 Sep 2024 9:10AM |
$1.520 |
$1.740 |
risen by
14.47%
|
|
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$301 |
Update - Notification of buy-back - PIA
|
11 Sep 2024 9:10AM |
$1.090 |
$1.170 |
risen by
7.34%
|
|
| Island Pharmaceuticals Limited (ILA) ORDINARY FULLY PAID |
Health Care |
$38 |
Binding LOI for proposed acquisition of Galidesivir
|
11 Sep 2024 9:09AM |
$0.077 |
$0.180 |
risen by
133.77%
|
|
ILA - Price-sensitive ASX Announcement
Full Release
Key Points
- Island Pharmaceuticals Limited has signed a binding Letter of Intent with BioCryst Pharmaceuticals, Inc. for the potential acquisition of the antiviral molecule galidesivir.
- Island will pay a US$50k option fee, securing an exclusive 12-month option to acquire the galidesivir program.
- Galidesivir has shown antiviral activity against over 20 RNA viruses, including Ebola, Zika, and Marburg viruses.
- The molecule has completed two Phase 1 human safety and tolerability trials and numerous animal efficacy studies.
- Regulatory due diligence will be conducted to explore approval via the FDA's Animal Rule pathway.
- The acquisition aligns with Island Pharmaceuticals' strategy to diversify its pipeline and address urgent viral diseases and medical countermeasures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$305 |
Further regarding Company Presentation
|
11 Sep 2024 9:07AM |
$0.460 |
$1.260 |
risen by
173.91%
|
|
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$301 |
NTA at 06.09.24 Pre-tax 125.53 Post-tax 125.82
|
11 Sep 2024 9:07AM |
$1.090 |
$1.170 |
risen by
7.34%
|
|
| CVC Limited (CVC) ORDINARY FULLY PAID |
Financials |
$236 |
Update - Notification of buy-back - CVC
|
11 Sep 2024 9:06AM |
$1.730 |
$2.020 |
risen by
16.76%
|
|
| Keypath Education International Inc (KED) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Merger Effective Time
|
11 Sep 2024 9:05AM |
$0.865 |
$0.865 |
fallen by
0%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
